What technical signals does GT Biopharma (GTBP) have?

GT Biopharma current technical signals: no active technical signal.

Is GT Biopharma a cup-and-handle pattern?

No. GT Biopharma has no valid Cup signal right now.

What published figures are available for GT Biopharma?

Market cap: $65.52M. Trailing 12 months PER: -0.4×. Latest quarter PBR: 2.65×. Dividend yield: 0.00%.

← Signal Board

GT Biopharma stock price

GT 바이오파머NASDAQ:GTBP · Nasdaq · Healthcare

$6.16+0.98%

2026-10-05 close · prelim

Today's signals · No active technical signal.

Signal details →

GT Biopharma last closed at $6.16 (+0.98%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -0.4×. Its overall grade ranks 683 of 739 stocks in Healthcare.

About this company

GT Biopharma last closed at $6.16 (+0.98%) on 2026-10-05. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall F · 683/739

Valuation grade C

Details →

Related stocks

Astellas PharmaCompetitor
면역항암·세포치료 파이프라인에서 경쟁하는 대형 제약사
Bristol Myers SquibbCompetitor
T세포 기반 항암제 및 면역항암 분야의 주요 경쟁사
Gilead SciencesCompetitor
세포치료·면역항암 관련 대형 바이오 기업

Details →

About GT Biopharma

What technical signals does GT Biopharma (GTBP) have?: GT Biopharma current technical signals: no active technical signal.
Is GT Biopharma a cup-and-handle pattern?: No. GT Biopharma has no valid Cup signal right now.
What published figures are available for GT Biopharma?: Market cap: $65.52M. Trailing 12 months PER: -0.4×. Latest quarter PBR: 2.65×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Turn what you saw on this name into a strategy

Ask Q about GT Biopharma, or open the plan table on the main site.

Ask Q ↗See plans ↗

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Quantus Signal · live data · not investment advice · Privacy Policy